ADMA Biologics, Inc. (ADMA)
19.80
+0.41
(+2.11%)
USD |
NASDAQ |
Dec 09, 13:20
ADMA Biologics EPS Diluted (Quarterly): 0.1489 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
| Arcutis Biotherapeutics, Inc. | 0.0558 |
| Exelixis, Inc. | 0.695 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 36.43M |
| Revenue (Quarterly) | 134.22M |
| Total Expenses (Quarterly) | 97.80M |
| Enterprise Value | 4.637B |
| Gross Profit Margin (Quarterly) | 56.31% |
| Profit Margin (Quarterly) | 27.14% |
| Earnings Yield | 4.30% |
| Operating Earnings Yield | 3.43% |
| Normalized Earnings Yield | 4.367 |